Showing results (131-140 of 244) with videos related to
Sort By:
Pageof 25
The Journal of Biological Chemistry|February 14, 1998
Molecular determinants of L-type Ca2+ channel inactivation. Segment exchange analysis of the carboxyl-terminal cytoplasmic motif encoded by exons 40-42 of the human alpha1C subunit geneN M Soldatov, M Oz, K A O'Brien, et al.Pharmacology|January 1, 1983
Pharmacokinetics of benzodiazepine hypnoticsD J Greenblatt, M Divoll, D R Abernethy, et al.The Journal of Pharmacology and Experimental Therapeutics|March 1, 1983
Differential effect of cimetidine on drug oxidation (antipyrine and diazepam) vs. conjugation (acetaminophen and lorazepam): prevention of acetaminophen toxicity by cimetidineD R Abernethy, D J Greenblatt, M Divoll, et al.Journal of Clinical Pharmacology|January 1, 1993
Antipyrine kinetics in patients with primary biliary cirrhosisL L von Moltke, D R Abernethy, M M Kaplan, et al.International Pharmacopsychiatry|January 1, 1982
Pharmacokinetics of benzodiazepine hypnoticsD J Greenblatt, M Divoll, D R Abernethy, et al.Annals of Internal Medicine|September 1, 1986
Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients. Altered electrocardiographic and hypotensive responsesD R Abernethy, J B Schwartz, E L Todd, et al.Obstetrics and Gynecology|September 1, 1982
Increased metabolic clearance of acetaminophen with oral contraceptive useD R Abernethy, M Divoll, H R Ochs, et al.Clinical Pharmacology and Therapeutics|October 21, 2011
Integration of diverse data sources for prediction of adverse drug eventsD R Abernethy, J P F Bai, K Burkhart, et al.Pharmacology|January 1, 1989
Oral 5-fluorouracil in psoriasis: pharmacokinetic-pharmacodynamic relationshipsD R Abernethy, J C Alper, M C Wiemann, et al.Clinical Pharmacokinetics|March 1, 1984
The influence of obesity on the pharmacokinetics of oral alprazolam and triazolamD R Abernethy, D J Greenblatt, M Divoll, et al.Pageof 25